Fungal Infection Treatment Guidelines
Introduction to Treatment
- For patients with fungal infection of the nail and underlying health conditions, such as liver disease, topical antifungal therapy is recommended as the first-line treatment, according to the British Journal of Dermatology guidelines 1
Topical Therapy
- Topical antifungal therapy, including amorolfine 5% nail lacquer applied once or twice weekly for 6-12 months, is a preferred treatment option for patients with liver conditions, with approximately 50% cure rates 1
- Alternative topical therapies include ciclopirox 8% lacquer applied once daily for up to 48 weeks, and efinaconazole 10% with mycological cure rates approaching 50% when applied daily for 48 weeks 1
- The American Academy of Pediatrics recommends terbinafine 1% cream applied twice daily for 1-2 weeks as an effective topical treatment for foot mycosis, with superior mycological cure rates compared to other antifungal creams 2
Combination Therapy
- Combination therapy with mechanical nail debridement plus topical agent may be considered to improve treatment outcomes, especially for thick nails or dermatophytoma 1
Systemic Therapy
- Systemic antifungal therapy, such as fluconazole 150-450mg once weekly, may be considered if absolutely necessary, with careful monitoring of liver function tests, as systemic antifungals like terbinafine and itraconazole can cause hepatotoxicity 1
- Oral terbinafine is the first-line treatment for toe fungal infection, with superior efficacy and lower relapse rates compared to other antifungal medications, and should be administered at 250 mg daily for 12-16 weeks for toenail infections 1
- Itraconazole is an alternative treatment option, effective against both dermatophytes and Candida, but has slightly lower efficacy than terbinafine and is contraindicated in heart failure 1
- Griseofulvin has lower efficacy and longer treatment duration, but is the only antifungal licensed for children with onychomycosis, and should be administered at 500-1000 mg daily for 12-18 months 1
Treatment Monitoring and Prevention
- Patients should be reviewed after 3 months to assess response, and treatment should be continued until clinical and mycological cure, with monitoring for local adverse effects and baseline liver function tests 1
- Preventive measures include keeping nails short and clean, wearing protective footwear, applying antifungal powders, and treating all infected family members simultaneously, as recurrence rates for onychomycosis are high, ranging from 40-70% 1, 2
- Simple measures such as applying foot powder after bathing, changing socks daily, and cleaning athletic footwear periodically can help prevent recurrence of foot mycosis, reducing the rates of T. pedis from 8.5% to 2.1% 2
Special Considerations
- Dermatophytoma may require surgical removal or mechanical intervention before antifungal therapy, and thick nails may require mechanical debridement or chemical avulsion with 40% urea before treatment 1
- Children should be treated with griseofulvin, the only licensed oral antifungal for this population, and Candida infections have greater efficacy with itraconazole than terbinafine 1
- Covering foot lesions with socks before wearing underwear can prevent spread to the groin area in individuals with recurrent infections 2